medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2014, Number 06

<< Back Next >>

Ginecol Obstet Mex 2014; 82 (06)

Contraception and breast feeding. Spacing of pregnancies. Present concepts

Buitrón-García-Figueroa R, Malanco-Hernández LM, Lara-Ricalde R, García-Hernández A

Language: Spanish
References: 9
Page: 389-393
PDF size: 314.10 Kb.


ABSTRACT

The risk of pregnancy in breastfeeding should be a concern of women. Family planning programs in the postnatal period contraceptive choices offer high efficiency. Breastfeeding is a natural contraception method (LAM) as a contraceptive shield has 98 % efficiency. Women should consider using an alternate contraceptive method when feeding requirements for this method to be effective are not met. Some of contraceptive alternatives in lactation include hormonal methods. According to the Medical Eligibility Criteria for Contraceptive Use WHO combined hormonal methods are contraindicated during breast feeding, hormonal progestogen only method are considered only in Group 3 and Group 1 immediate postpartum after 6 weeks postpartum. There are modifications to these criteria by the CDC and the UK for the use of these hormones in early in lactation-


REFERENCES

  1. Buitrón G R, Lara R R. Lactancia y anticoncepción. En: Reyes V H, Martínez GA. Lactancia Humana. 1ª ed. México: Interamericana; 276-279.

  2. Kennedy KI, Trusell J. Postpartum contraception and lactation. In: Hatcher R A, Trusell J, Nelson A L. Contraceptive technology (20th revised). Ardent Media 2011;483-511.

  3. Organización Mundial de la Salud. Criterios médicos de elegibilidad para el uso de anticonceptivos. Método de amenorrea de lactancia. 3ª ed. 2005;1.

  4. Organización Mundial de la Salud. Criterios médicos de elegibilidad para el uso de anticonceptivos. Anticonceptivos inyectables, parche y anillo vaginal combinados. 3ª ed. 2005;3.

  5. Organización Mundial de la Salud. Criterios médicos de elegibilidad para el uso de anticonceptivos. Anticonceptivos de progestina sola. 3ª ed. 2005;2.

  6. Curtis KM. US Medical eligibility criteria. In: Hatcher RA, Trusell J, Nelson AL. Contraceptive technology (20th revised). Ardent Media 2011;75-99.

  7. UK Medical Elegibility Criteria for Contraceptive Use. Progestogen-only methods. 2009;47-62.

  8. Shwan E. Lactogenesis after early postpartum use of the contraceptive implant. Obstetrics & Gynecology 2011;117:1114-1121.

  9. Brito M B, Alberto FR, Quintana SM, Holanda DM, Silva S M, Sales VC. Safety of etonoestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception 2009:80;519-526.




2020     |     www.medigraphic.com